Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Granisetron"" wg kryterium: Temat


Tytuł:
A double-blind, randomized, multicenter phase 3 study of palonosetron vs granisetron combined with dexamethasone and fosaprepitant to prevent chemotherapy-induced nausea and vomiting in patients with breast cancer receiving anthracycline and cyclophosphamide.
Autorzy:
Matsumoto K; Hyogo Cancer Center, Hyogo, Japan.
Takahashi M; NHO Hokkaido Cancer Center, Hokkaido, Japan.
Sato K; Tokyo-West Tokushukai Hospital, Tokyo, Japan.
Osaki A; Saitama Medical University, Saitama, Japan.
Takano T; Toranomon Hospital, Tokyo, Japan.
Naito Y; National Cancer Center Hospital East, Kashiwa, Japan.
Matsuura K; Hiroshima Prefectural Hospital, Hiroshima, Japan.
Aogi K; Shikoku Cancer Center, Ehime, Japan.
Fujiwara K; Kindai University Hospital, Osaka, Japan.
Tamura K; National Cancer Center Hospital, Tokyo, Japan.
Baba M; Hokkaido University, Hokkaido, Japan.
Tokunaga S; Osaka City General Hospital, Osaka, Japan.
Hirano G; Kyushu Hospital, Fukuoka, Japan.
Imoto S; Kyorin University, Tokyo, Japan.
Miyazaki C; Jichi Medical University, Tochigi, Japan.
Yanagihara K; Kansai Electric Power Hospital, Osaka, Japan.
Imamura CK; Advanced Cancer Translational Research Institute, Showa University, Tokyo, Japan.
Chiba Y; Kindai University Hospital, Osaka, Japan.
Saeki T; Saitama Medical University, Saitama, Japan.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2020 May; Vol. 9 (10), pp. 3319-3327. Date of Electronic Publication: 2020 Mar 13.
Typ publikacji:
Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms:
Antiemetics/*therapeutic use
Antineoplastic Combined Chemotherapy Protocols/*adverse effects
Breast Neoplasms/*drug therapy
Dexamethasone/*therapeutic use
Granisetron/*therapeutic use
Morpholines/*therapeutic use
Nausea/*prevention & control
Palonosetron/*therapeutic use
Vomiting/*prevention & control
Adult ; Aged ; Aged, 80 and over ; Cyclophosphamide/administration & dosage ; Double-Blind Method ; Doxorubicin/administration & dosage ; Drug Therapy, Combination ; Epirubicin/administration & dosage ; Female ; Fluorouracil/administration & dosage ; Humans ; Middle Aged ; Nausea/chemically induced ; Patient Reported Outcome Measures ; Vomiting/chemically induced
Czasopismo naukowe
Tytuł:
Development and evaluation of a sublingual film of the antiemetic granisetron hydrochloride.
Autorzy:
Kalia V; a Department of Pharmaceutics , ISF College of Pharmacy , Moga , Punjab , India.
Garg T; a Department of Pharmaceutics , ISF College of Pharmacy , Moga , Punjab , India.
Rath G; a Department of Pharmaceutics , ISF College of Pharmacy , Moga , Punjab , India.
Goyal AK; a Department of Pharmaceutics , ISF College of Pharmacy , Moga , Punjab , India.
Pokaż więcej
Źródło:
Artificial cells, nanomedicine, and biotechnology [Artif Cells Nanomed Biotechnol] 2016 May; Vol. 44 (3), pp. 842-6. Date of Electronic Publication: 2014 Dec 01.
Typ publikacji:
Journal Article
MeSH Terms:
Antiemetics*/chemistry
Antiemetics*/pharmacokinetics
Antiemetics*/pharmacology
Granisetron*/chemistry
Granisetron*/pharmacokinetics
Granisetron*/pharmacology
Hypromellose Derivatives*/chemistry
Hypromellose Derivatives*/pharmacokinetics
Hypromellose Derivatives*/pharmacology
Mouth Floor*
Polyvinyls*/chemistry
Polyvinyls*/pharmacokinetics
Polyvinyls*/pharmacology
Drug Delivery Systems/*methods
Administration, Oral ; Animals ; Drug Evaluation, Preclinical ; Goats
Czasopismo naukowe
Tytuł:
Alterations of colonic sensitivity and gastric dysmotility after acute cisplatin and granisetron.
Autorzy:
Martín-Ruíz M; Departamento de Biología, Facultad de Ciencias, Universidad Autónoma de Madrid, Madrid, Spain.
Uranga JA; Departamento de Ciencias Básicas de la Salud, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, Alcorcón, Madrid, Spain.; Unidad Asociada I+D+i al Instituto de Investigación en Ciencias de la Alimentación, CIAL (CSIC), Madrid, Spain.; Grupo de Excelencia Investigadora URJC-Banco de Santander-Grupo Multidisciplinar de Investigación y Tratamiento del Dolor (i+DOL), Madrid, Spain.
Mosinska P; Department of Biochemistry, Faculty of Medicine, Medical University of Lodz, Lodz, Poland.
Fichna J; Department of Biochemistry, Faculty of Medicine, Medical University of Lodz, Lodz, Poland.
Nurgali K; College of Health and Biomedicine, Institute for Health and Sport, Victoria University, Melbourne, Victoria, Australia.; Australian Institute for Musculoskeletal Science (AIMSS), Melbourne, Victoria, Australia.; Department of Medicine Western Health, The University of Melbourne, Victoria, Australia.
Martín-Fontelles MI; Departamento de Ciencias Básicas de la Salud, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, Alcorcón, Madrid, Spain.; Unidad Asociada I+D+i al Instituto de Investigación en Ciencias de la Alimentación, CIAL (CSIC), Madrid, Spain.; Grupo de Excelencia Investigadora URJC-Banco de Santander-Grupo Multidisciplinar de Investigación y Tratamiento del Dolor (i+DOL), Madrid, Spain.; Unidad Asociada I+D+i al Instituto de Química Médica, IQM (CSIC), Madrid, Spain.
Abalo R; Departamento de Ciencias Básicas de la Salud, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, Alcorcón, Madrid, Spain.; Unidad Asociada I+D+i al Instituto de Investigación en Ciencias de la Alimentación, CIAL (CSIC), Madrid, Spain.; Grupo de Excelencia Investigadora URJC-Banco de Santander-Grupo Multidisciplinar de Investigación y Tratamiento del Dolor (i+DOL), Madrid, Spain.; Unidad Asociada I+D+i al Instituto de Química Médica, IQM (CSIC), Madrid, Spain.
Pokaż więcej
Źródło:
Neurogastroenterology and motility [Neurogastroenterol Motil] 2019 Mar; Vol. 31 (3), pp. e13499. Date of Electronic Publication: 2018 Nov 06.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antiemetics/*pharmacology
Antineoplastic Agents/*pharmacology
Cisplatin/*antagonists & inhibitors
Cisplatin/*pharmacology
Colon/*drug effects
Gastrointestinal Motility/*drug effects
Granisetron/*pharmacology
Serotonin Antagonists/*pharmacology
Stomach/*drug effects
Animals ; Colon/pathology ; Male ; Nausea/chemically induced ; Nausea/psychology ; Organ Size/drug effects ; Rats ; Rats, Wistar ; Stomach/pathology
Czasopismo naukowe
Tytuł:
In vitro percutaneous absorption enhancement of granisetron by chemical penetration enhancers.
Autorzy:
Zhao N; School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning, China.
Cun D
Li W
Ma X
Sun L
Xi H
Li L
Fang L
Pokaż więcej
Źródło:
Drug development and industrial pharmacy [Drug Dev Ind Pharm] 2013 Apr; Vol. 39 (4), pp. 561-8. Date of Electronic Publication: 2012 Mar 19.
Typ publikacji:
Journal Article
MeSH Terms:
Skin Absorption*
Antiemetics/*pharmacokinetics
Granisetron/*pharmacokinetics
Myristates/*chemistry
Skin/*metabolism
Administration, Cutaneous ; Animals ; Antiemetics/chemistry ; Granisetron/chemistry ; Male ; Permeability/drug effects ; Rabbits
Czasopismo naukowe
Tytuł:
Palonosetron versus granisetron in combination with aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with gynecologic cancer.
Autorzy:
Fujiwara S; Department of Obstetrics and Gynecology, Osaka Medical College, Osaka, Japan.
Terai Y; Department of Obstetrics and Gynecology, Osaka Medical College, Osaka, Japan. .
Tsunetoh S; Department of Obstetrics and Gynecology, Osaka Medical College, Osaka, Japan.
Sasaki H; Department of Obstetrics and Gynecology, Osaka Medical College, Osaka, Japan.
Kanemura M; Department of Obstetrics and Gynecology, Osaka Medical College, Osaka, Japan.
Ohmichi M; Department of Obstetrics and Gynecology, Osaka Medical College, Osaka, Japan.
Pokaż więcej
Źródło:
Journal of gynecologic oncology [J Gynecol Oncol] 2015 Oct; Vol. 26 (4), pp. 311-9. Date of Electronic Publication: 2015 Jul 20.
Typ publikacji:
Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Antiemetics/*administration & dosage
Genital Neoplasms, Female/*drug therapy
Nausea/*prevention & control
Vomiting/*prevention & control
Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Aprepitant ; Carboplatin/administration & dosage ; Carboplatin/adverse effects ; Cross-Over Studies ; Diet ; Drug Administration Schedule ; Female ; Granisetron/administration & dosage ; Humans ; Isoquinolines/administration & dosage ; Middle Aged ; Morpholines/administration & dosage ; Nausea/chemically induced ; Paclitaxel/administration & dosage ; Paclitaxel/adverse effects ; Palonosetron ; Quinuclidines/administration & dosage ; Serotonin 5-HT3 Receptor Antagonists ; Vomiting/chemically induced
Czasopismo naukowe
Tytuł:
Tropisetron, ondansetron, and granisetron for control of chemotherapy-induced emesis in Turkish cancer patients: a comparison of efficacy, side-effect profile, and cost.
Autorzy:
Abali H; S.B. Ankara Numune Hastanesi Medikal Onkoloji Kliniği, Ankara, Türkiye. />Celik I
Pokaż więcej
Źródło:
Cancer investigation [Cancer Invest] 2007 Apr-May; Vol. 25 (3), pp. 135-9.
Typ publikacji:
Clinical Trial; Comparative Study; Journal Article
MeSH Terms:
Antiemetics/*therapeutic use
Antineoplastic Agents/*adverse effects
Granisetron/*therapeutic use
Indoles/*therapeutic use
Ondansetron/*therapeutic use
Serotonin Antagonists/*therapeutic use
Vomiting/*drug therapy
Adult ; Aged ; Antiemetics/adverse effects ; Antiemetics/economics ; Antineoplastic Agents/economics ; Cost-Benefit Analysis ; Drug Costs ; Female ; Granisetron/adverse effects ; Granisetron/economics ; Headache/chemically induced ; Humans ; Indoles/adverse effects ; Indoles/economics ; Male ; Middle Aged ; Ondansetron/adverse effects ; Ondansetron/economics ; Prospective Studies ; Serotonin Antagonists/adverse effects ; Serotonin Antagonists/economics ; Treatment Outcome ; Tropisetron ; Turkey ; Vomiting/chemically induced ; Vomiting/economics
Czasopismo naukowe
Tytuł:
Efficacy of triplet regimen antiemetic therapy for chemotherapy-induced nausea and vomiting (CINV) in bone and soft tissue sarcoma patients receiving highly emetogenic chemotherapy, and an efficacy comparison of single-shot palonosetron and consecutive-day granisetron for CINV in a randomized, single-blinded crossover study.
Autorzy:
Kimura H; Department of Orthopaedic Surgery, Graduate School of Medical Science, Kanazawa University, Kanazawa, Ishikawa, 920-8641, Japan.
Yamamoto N
Shirai T
Nishida H
Hayashi K
Tanzawa Y
Takeuchi A
Igarashi K
Inatani H
Shimozaki S
Kato T
Aoki Y
Higuchi T
Tsuchiya H
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2015 Mar; Vol. 4 (3), pp. 333-41. Date of Electronic Publication: 2014 Dec 23.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Antiemetics/*therapeutic use
Dexamethasone/*therapeutic use
Nausea/*drug therapy
Neurokinin-1 Receptor Antagonists/*therapeutic use
Serotonin 5-HT3 Receptor Antagonists/*therapeutic use
Vomiting/*drug therapy
Adolescent ; Adult ; Aged ; Antiemetics/administration & dosage ; Antineoplastic Agents/adverse effects ; Aprepitant ; Bone Neoplasms/drug therapy ; Cross-Over Studies ; Dexamethasone/administration & dosage ; Drug Administration Schedule ; Drug Therapy, Combination ; Female ; Granisetron/administration & dosage ; Granisetron/therapeutic use ; Humans ; Isoquinolines/administration & dosage ; Isoquinolines/therapeutic use ; Male ; Middle Aged ; Morpholines/administration & dosage ; Morpholines/therapeutic use ; Nausea/chemically induced ; Neurokinin-1 Receptor Antagonists/administration & dosage ; Palonosetron ; Quinuclidines/administration & dosage ; Quinuclidines/therapeutic use ; Sarcoma/drug therapy ; Serotonin 5-HT3 Receptor Antagonists/administration & dosage ; Treatment Outcome ; Vomiting/chemically induced ; Young Adult
Czasopismo naukowe
Tytuł:
Is ondansetron more effective than granisetron for chemotherapy-induced nausea and vomiting? A review of comparative trials.
Autorzy:
Vrabel M; Oncology Nursing Society, Pittsburgh, PA, USA.
Pokaż więcej
Źródło:
Clinical journal of oncology nursing [Clin J Oncol Nurs] 2007 Dec; Vol. 11 (6), pp. 809-13.
Typ publikacji:
Comparative Study; Journal Article; Review
MeSH Terms:
Nausea*/chemically induced
Nausea*/drug therapy
Vomiting*/chemically induced
Vomiting*/drug therapy
Antiemetics/*therapeutic use
Granisetron/*therapeutic use
Ondansetron/*therapeutic use
Antiemetics/adverse effects ; Antineoplastic Agents/adverse effects ; Clinical Trials as Topic ; Evidence-Based Medicine ; Granisetron/adverse effects ; Humans ; Meta-Analysis as Topic ; Ondansetron/adverse effects ; Practice Guidelines as Topic ; Randomized Controlled Trials as Topic ; Research Design ; Serotonin Antagonists/therapeutic use ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Control of shivering during regional anaesthesia: prophylactic ketamine and granisetron.
Autorzy:
Sagir O; Inonu University, School of Medicine, Malatya, Turkey. />Gulhas N
Toprak H
Yucel A
Begec Z
Ersoy O
Pokaż więcej
Źródło:
Acta anaesthesiologica Scandinavica [Acta Anaesthesiol Scand] 2007 Jan; Vol. 51 (1), pp. 44-9.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Premedication*
Shivering*
Anesthesia, Spinal/*adverse effects
Antiemetics/*therapeutic use
Granisetron/*administration & dosage
Ketamine/*administration & dosage
Adult ; Anesthetics, Dissociative ; Body Temperature ; Double-Blind Method ; Female ; Granisetron/adverse effects ; Humans ; Intraoperative Complications/prevention & control ; Ketamine/adverse effects ; Male ; Postoperative Nausea and Vomiting ; Serotonin Antagonists
Czasopismo naukowe
Tytuł:
Palonosetron with aprepitant plus dexamethasone to prevent chemotherapy-induced nausea and vomiting during gemcitabine/cisplatin in urothelial cancer patients.
Autorzy:
Kitamura H; Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan.
Takahashi A; Department of Urology, Hakodate Goryoukaku Hospital, Hakodate, Hokkaido, Japan.
Hotta H; Department of Urology, Japanese Red Cross Asahikawa Hospital, Asahikawa, Hokkaido, Japan.
Kato R; Department of Urology, Muroran City General Hospital, Muroran, Hokkaido, Japan.
Kunishima Y; Department of Urology, Obihiro Kyokai Hospital, Obihiro, Hokkaido, Japan.
Takei F; Department of Urology, Sunagawa City Medical Center, Sunagawa, Hokkaido, Japan.
Horita H; Department of Urology, Saiseikai Otaru Hospital, Otaru, Hokkaido, Japan.
Masumori N; Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan.
Pokaż więcej
Corporate Authors:
Sapporo Medical University Urologic Oncology Consortium
Źródło:
International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2015 Oct; Vol. 22 (10), pp. 911-4. Date of Electronic Publication: 2015 Jun 18.
Typ publikacji:
Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Antiemetics/*therapeutic use
Antineoplastic Combined Chemotherapy Protocols/*adverse effects
Carcinoma, Transitional Cell/*drug therapy
Nausea/*prevention & control
Serotonin Antagonists/*therapeutic use
Urologic Neoplasms/*drug therapy
Vomiting/*prevention & control
Adult ; Aged ; Aged, 80 and over ; Aprepitant ; Cisplatin/administration & dosage ; Cisplatin/adverse effects ; Deoxycytidine/administration & dosage ; Deoxycytidine/adverse effects ; Deoxycytidine/analogs & derivatives ; Dexamethasone/therapeutic use ; Drug Therapy, Combination ; Female ; Granisetron/therapeutic use ; Humans ; Isoquinolines/therapeutic use ; Kidney Neoplasms/drug therapy ; Male ; Middle Aged ; Morpholines/therapeutic use ; Nausea/chemically induced ; Ondansetron/therapeutic use ; Palonosetron ; Quinuclidines/therapeutic use ; Retrospective Studies ; Serotonin 5-HT3 Receptor Antagonists/therapeutic use ; Ureteral Neoplasms/drug therapy ; Urinary Bladder Neoplasms/drug therapy ; Vomiting/chemically induced ; Gemcitabine
Czasopismo naukowe
Tytuł:
Compatibility of butorphanol with granisetron in 0.9% sodium chloride injection packaged in glass bottles or polyolefin bags.
Autorzy:
Chen FC; Fu-Chao Chen, M.Pharm., is Clinical Pharmacist, Department of Clinical Pharmacy, Dongfeng Hospital, Hubei University of Medicine, Shiyan, China. Hui Xiong, M.Pharm., is Director, Department of Pharmacy, Renmin Hospital, Hubei University of Medicine. Hui-Min Liu, M.Pharm., is Clinical Pharmacist, Department of Clinical Pharmacy, Dongfeng Hospital. Bao-Xia Fang, B.S.Pharm., is Hospital Pharmacist; and Peng Li, Pharm.D., is Director, Department of Pharmacy, Dongfeng Hospital. .
Xiong H; Fu-Chao Chen, M.Pharm., is Clinical Pharmacist, Department of Clinical Pharmacy, Dongfeng Hospital, Hubei University of Medicine, Shiyan, China. Hui Xiong, M.Pharm., is Director, Department of Pharmacy, Renmin Hospital, Hubei University of Medicine. Hui-Min Liu, M.Pharm., is Clinical Pharmacist, Department of Clinical Pharmacy, Dongfeng Hospital. Bao-Xia Fang, B.S.Pharm., is Hospital Pharmacist; and Peng Li, Pharm.D., is Director, Department of Pharmacy, Dongfeng Hospital.
Liu HM; Fu-Chao Chen, M.Pharm., is Clinical Pharmacist, Department of Clinical Pharmacy, Dongfeng Hospital, Hubei University of Medicine, Shiyan, China. Hui Xiong, M.Pharm., is Director, Department of Pharmacy, Renmin Hospital, Hubei University of Medicine. Hui-Min Liu, M.Pharm., is Clinical Pharmacist, Department of Clinical Pharmacy, Dongfeng Hospital. Bao-Xia Fang, B.S.Pharm., is Hospital Pharmacist; and Peng Li, Pharm.D., is Director, Department of Pharmacy, Dongfeng Hospital.
Fang BX; Fu-Chao Chen, M.Pharm., is Clinical Pharmacist, Department of Clinical Pharmacy, Dongfeng Hospital, Hubei University of Medicine, Shiyan, China. Hui Xiong, M.Pharm., is Director, Department of Pharmacy, Renmin Hospital, Hubei University of Medicine. Hui-Min Liu, M.Pharm., is Clinical Pharmacist, Department of Clinical Pharmacy, Dongfeng Hospital. Bao-Xia Fang, B.S.Pharm., is Hospital Pharmacist; and Peng Li, Pharm.D., is Director, Department of Pharmacy, Dongfeng Hospital.
Li P; Fu-Chao Chen, M.Pharm., is Clinical Pharmacist, Department of Clinical Pharmacy, Dongfeng Hospital, Hubei University of Medicine, Shiyan, China. Hui Xiong, M.Pharm., is Director, Department of Pharmacy, Renmin Hospital, Hubei University of Medicine. Hui-Min Liu, M.Pharm., is Clinical Pharmacist, Department of Clinical Pharmacy, Dongfeng Hospital. Bao-Xia Fang, B.S.Pharm., is Hospital Pharmacist; and Peng Li, Pharm.D., is Director, Department of Pharmacy, Dongfeng Hospital.
Pokaż więcej
Źródło:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2015 Aug 15; Vol. 72 (16), pp. 1374-8.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Drug Stability*
Injections, Intravenous*
Antiemetics/*administration & dosage
Butorphanol/*administration & dosage
Drug Packaging/*methods
Granisetron/*administration & dosage
Narcotics/*administration & dosage
Sodium Chloride/*administration & dosage
Czasopismo naukowe
Tytuł:
Granisetron vs ondansetron for prevention of nausea and vomiting in hematopoietic stem cell transplant patients: results of a prospective, double-blind, randomized trial.
Autorzy:
Walsh T; South Texas Veterans Health Care System, Audie L Murphy Division, San Antonio, TX 78229, USA. />Morris AK
Holle LM
Callander N
Bradshaw P
Valley AW
Clark G
Freytes CO
Pokaż więcej
Źródło:
Bone marrow transplantation [Bone Marrow Transplant] 2004 Dec; Vol. 34 (11), pp. 963-8.
Typ publikacji:
Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Hematopoietic Stem Cell Transplantation*
Antiemetics/*administration & dosage
Granisetron/*administration & dosage
Nausea/*prevention & control
Ondansetron/*administration & dosage
Transplantation Conditioning/*adverse effects
Vomiting/*prevention & control
Antiemetics/adverse effects ; Double-Blind Method ; Female ; Granisetron/adverse effects ; Humans ; Male ; Middle Aged ; Multicenter Studies as Topic ; Nausea/etiology ; Ondansetron/adverse effects ; Prospective Studies ; Vomiting/etiology
Czasopismo naukowe
Tytuł:
Disturbing post-operative symptoms are not reduced by prophylactic antiemetic treatment in patients at high risk of post-operative nausea and vomiting.
Autorzy:
Alkaissi A; Departments of Anesthesiology and Intensive Care, University Hospital in Linköping, Sweden. />Gunnarsson H
Johnsson V
Evertsson K
Ofenbartl L
Kalman S
Pokaż więcej
Źródło:
Acta anaesthesiologica Scandinavica [Acta Anaesthesiol Scand] 2004 Jul; Vol. 48 (6), pp. 761-71.
Typ publikacji:
Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Antiemetics/*therapeutic use
Droperidol/*therapeutic use
Granisetron/*therapeutic use
Postoperative Complications/*prevention & control
Postoperative Nausea and Vomiting/*prevention & control
Adult ; Antiemetics/economics ; Double-Blind Method ; Droperidol/economics ; Female ; Granisetron/economics ; Gynecologic Surgical Procedures/adverse effects ; Gynecologic Surgical Procedures/methods ; Humans ; Middle Aged ; Pain Measurement ; Phenothiazines/economics ; Phenothiazines/therapeutic use ; Postoperative Nausea and Vomiting/economics ; Postoperative Nausea and Vomiting/physiopathology ; Prospective Studies ; Risk ; Severity of Illness Index ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł:
Antiemetic effectiveness of ondansetron and granisetron in patients with breast cancer treated with cyclophosphamide.
Autorzy:
Dempsey CL; EPI-Q, Inc., Oakbrook Terrace, IL 60181, USA.
Coop AJ
Shillington A
Farley PA
Eberhardt DR
O'Briant S
Pokaż więcej
Źródło:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2004 Apr 15; Vol. 61 (8), pp. 781-6.
Typ publikacji:
Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Antiemetics/*therapeutic use
Antineoplastic Agents/*therapeutic use
Breast Neoplasms/*drug therapy
Cyclophosphamide/*therapeutic use
Granisetron/*therapeutic use
Ondansetron/*therapeutic use
Adult ; Antiemetics/administration & dosage ; Antineoplastic Agents/administration & dosage ; Antineoplastic Agents/adverse effects ; Cancer Care Facilities ; Cohort Studies ; Cyclophosphamide/administration & dosage ; Cyclophosphamide/adverse effects ; Dexamethasone/administration & dosage ; Dexamethasone/pharmacology ; Dose-Response Relationship, Drug ; Drug Administration Schedule ; Drug Therapy, Combination ; Granisetron/administration & dosage ; Humans ; Infusions, Intravenous ; Injections, Intravenous ; Logistic Models ; Middle Aged ; Nausea/chemically induced ; Nausea/epidemiology ; Nausea/prevention & control ; Ondansetron/administration & dosage ; Retrospective Studies ; Time Factors ; Vomiting/chemically induced ; Vomiting/epidemiology ; Vomiting/prevention & control
Czasopismo naukowe
Tytuł:
Single-dose oral granisetron versus multidose intravenous ondansetron for moderately emetogenic cyclophosphamide-based chemotherapy in pediatric outpatients with acute lymphoblastic leukemia.
Autorzy:
Jaing TH; Divisions of Hematology and Oncology, Department of Pediatrics, Chang Gung Children's Hospital, 5 Fu-Shin Street, Kwei-Shan 333, Taoyuan, Taiwan. />Tsay PK
Hung IJ
Yang CP
Hu WY
Pokaż więcej
Źródło:
Pediatric hematology and oncology [Pediatr Hematol Oncol] 2004 Apr-May; Vol. 21 (3), pp. 227-35.
Typ publikacji:
Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antiemetics/*administration & dosage
Antineoplastic Combined Chemotherapy Protocols/*adverse effects
Granisetron/*administration & dosage
Ondansetron/*administration & dosage
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*drug therapy
Vomiting/*prevention & control
Antiemetics/economics ; Antiemetics/standards ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Child ; Child, Preschool ; Cyclophosphamide/adverse effects ; Cyclophosphamide/therapeutic use ; Female ; Granisetron/economics ; Humans ; Male ; Ondansetron/economics ; Outpatients ; Sex Factors ; Treatment Outcome ; Vomiting/chemically induced
Czasopismo naukowe
Tytuł:
The efficacy and safety of once-daily Kytril (granisetron hydrochloride) tablets in the prophylaxis of nausea and emesis following fractionated upper abdominal radiotherapy.
Autorzy:
Lanciano R; Department of Radiation Oncology, Delaware County Memorial Hospital, Drexel Hill, Pennsylvania 19026, USA.
Sherman DM
Michalski J
Preston AJ
Yocom K
Friedman C
Pokaż więcej
Źródło:
Cancer investigation [Cancer Invest] 2001; Vol. 19 (8), pp. 763-72.
Typ publikacji:
Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms:
Dose Fractionation, Radiation*
Abdomen/*radiation effects
Antiemetics/*therapeutic use
Granisetron/*therapeutic use
Nausea/*prevention & control
Neoplasms/*radiotherapy
Radiotherapy/*adverse effects
Vomiting/*prevention & control
Adult ; Aged ; Aged, 80 and over ; Double-Blind Method ; Drug Administration Schedule ; Female ; Granisetron/administration & dosage ; Granisetron/adverse effects ; Humans ; Male ; Middle Aged ; Tablets
Czasopismo naukowe
Tytuł:
Patient outcomes after therapeutic interchange of dolasetron for granisetron.
Autorzy:
Steiner MA; Center for Drug Policy and Clinical Economics, University of Wisconsin Hospitals and Clinics, 600 Highland Avenue F6/133-1530, Madison, WI 53792, USA. />Yorgason RZ
Vermeulen LC
Theisen J
Pokaż więcej
Źródło:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2003 May 15; Vol. 60 (10), pp. 1023-8.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antiemetics/*pharmacokinetics
Granisetron/*pharmacokinetics
Indoles/*pharmacokinetics
Nausea/*prevention & control
Quinolizines/*pharmacokinetics
Vomiting/*prevention & control
Adult ; Aged ; Aged, 80 and over ; Antiemetics/therapeutic use ; Antineoplastic Agents/adverse effects ; Cohort Studies ; Female ; Granisetron/therapeutic use ; Humans ; Indoles/therapeutic use ; Male ; Middle Aged ; Nausea/chemically induced ; Quinolizines/therapeutic use ; Therapeutic Equivalency ; Treatment Outcome ; United States ; Vomiting/chemically induced
Czasopismo naukowe
Tytuł:
Comparison of granisetron and granisetron plus dexamethasone for the prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy.
Autorzy:
Biswas BN; Department of Anesthesiology, Calcutta National Medical College and Hospital, India. />Rudra A
Pokaż więcej
Źródło:
Acta anaesthesiologica Scandinavica [Acta Anaesthesiol Scand] 2003 Jan; Vol. 47 (1), pp. 79-83.
Typ publikacji:
Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
MeSH Terms:
Antiemetics/*therapeutic use
Cholecystectomy, Laparoscopic/*adverse effects
Dexamethasone/*therapeutic use
Granisetron/*therapeutic use
Postoperative Nausea and Vomiting/*prevention & control
Adult ; Anesthesia, General ; Antiemetics/adverse effects ; Dexamethasone/adverse effects ; Double-Blind Method ; Drug Therapy, Combination ; Female ; Granisetron/adverse effects ; Humans ; Male ; Middle Aged
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies